Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial

BACKGROUND: Neonates born to women infected with HIV are at increased risk for invasive group B streptococcus (GBS) disease. We aimed to compare safety and immunogenicity of trivalent glycoconjugate GBS vaccine in pregnant women with and without HIV in Malawi and South Africa. METHODS: In our non-ra...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Lancet Infect Dis
Auteurs principaux: Heyderman, Robert S, Madhi, Shabir A, French, Neil, Cutland, Clare, Ngwira, Bagrey, Kayambo, Doris, Mboizi, Robert, Koen, Anthonet, Jose, Lisa, Olugbosi, Morounfolu, Wittke, Frederik, Slobod, Karen, Dull, Peter M
Format: Artigo
Langue:Inglês
Publié: Elsevier Science ;, The Lancet Pub. Group 2016
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4835545/
https://ncbi.nlm.nih.gov/pubmed/26869376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(15)00484-3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires